Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Both sides next revision |
stephanie_carlin [2022/05/01 20:50]
liam [Funding] | stephanie_carlin [2022/05/01 20:55] (current)
liam [Funding] |
|---|
| practice thrombosis residency program.((Carlin, S. (2021, February 10). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220501184628/https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Drugs-and-Biologics-Clinical-Practice-Guidelines-Working-Group_Stephanie-Carlin-1.pdf)) | practice thrombosis residency program.((Carlin, S. (2021, February 10). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220501184628/https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Drugs-and-Biologics-Clinical-Practice-Guidelines-Working-Group_Stephanie-Carlin-1.pdf)) |
| |
| She also received joint payment from [[pharmaceutical_companies:Bristol-Myers Squibb]] and [[pharmaceutical_companies:Pfizer]] for an "educational presentation to health professionals on atrial fibrillation. | She also received joint payment from [[pharmaceutical_companies:Bristol-Myers Squibb]] and [[pharmaceutical_companies:Pfizer]] for an "educational presentation to health professionals on atrial fibrillation.((Carlin, S., & Eikelboom, J. (2022). //Advances in anticoagulation: patients with bioprosthetic heart valves.// Cardiovascular Research, 118(3), e26–e28. https://doi.org/10.1093/cvr/cvab360)) |
